Bryan
Jones, PhD
Chief Executive Officer
30+ years in biotech leadership and drug development, including biologics, small molecules and drug device programs. Deep expertise in clinical strategy and business development and growing startup organizations.
Dane
Callow
Chief Financial Officer
Life sciences finance and operations leader with nearly two decades of experience stepping into high-impact leadership roles for organizations ranging from venture-backed startups to publicly traded companies.
Dvorit Samid, PhD
Chief Scientific Advisor
Former Differentiation Therapy Section Chief at NCI and subsequently nearly 3 decades of pharmaceutical/biotech leadership, playing a key role in drug development, strategic alliances and commercialization.
Emel Guldogan
Chief Clinical Development Officer
Clinical development leader with a strong track record in global clinical trial execution, regulatory strategy across biotech and pharmaceutical companies, FDA/ICH compliance and CRO partnerships.
Experienced Management Team
Demonstrated success in advancing drug development programs, regulatory approval and commercialization